FDA Guidance Directs Researchers On Use Of Patient Advocates

A new guidance document from the US agency offers advice on how sponsors can use patient advocates to improve and streamline device clinical trials.

Healthcare-provider
• Source: Shutterstock

In recent years, the medical device industry has become increasingly aware of the important role patients should play in developing new technologies. However, shaping that engagement during the clinical trial process has remained a challenge. A new draft guidance document from the US Food and Drug Administration attempts to fill that gap by discussing ways sponsors can use patient experience and perspectives to better the design and conduct of device clinical trials.

Discussions at the October 2017 meeting of the Patient Engagement Advisory Committee (PEAC) shaped the document, acting FDA commissioner Ned Sharpless says. The meeting, which focused on overcoming barriers to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Guidance

More from Compliance